FDA is strengthening warnings in the febuxostat (Uloric) product labeling and has added a Medication Guide requirement because of an increased risk of cardiovascular death and all-cause mortality.
FDA issued recall of sterile saline and sterile water for inhalation by Medex Cardio-Pulmonary, doing business as Smiths Medical due to potential exposure to infectious agents as a result of...
FDA issued recall of Infants’ Ibuprofen Concentrated Oral Suspension by Tris Pharma due to potential higher concentrations of ibuprofen; three additional lots added.
FDA issued recall of Synergy Cranial software and Stealth Station S7 Cranial software by Medtronic due to inaccuracies displayed during surgical procedures.